abemaciclib,lasofoxifene
pfizer,ligand,sermonix,eli lilly
['abemaciclib', 'breast', 'abema', 'lasofoxifene']
as per the data shown at the , lasofoxifene/abemaciclib combination exhibited excellent therapeutic effectiveness in mesr1, er+/her2- metastatic breast cancer patients who developed resistance to endocrine therapy &amp; cdk4/6 inhibitors. learn more: 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry